APTEKA+, OOO, Moscow Oblast

Accounting reports

Previously

Name	APTEKA+, OOO
INN	5050108802
KPP	505001001
OGRN	1145050000303
OKPO	31314651
Address	141143, Moskovskaya Oblast', g Schelkovo, d Medvezh'i Ozera, ul Sadovaya, d. K. 1
Phone	+7 (926) 225-40-75

Extract from EGRUL $12 (€10)

Last name, first name & patronymic of the General Director

List of founders

Position of the company

Licenses

Authorized capital

Branches

Complete structure of the extract

Download an extract from EGRUL

We guarantee to provide you with an actual
information extract

OKVED code	Type	Name of activity type
Data on types of economic activities APTEKA+, OOO according to EGRUL
47.73	Core activity	Retailing drugs in specialized stores (pharmacies)
46.46	Additional activity	Wholesale of pharmaceutical goods
47.74	Additional activity	Retailing products used for medical purposes, orthopedic goods in specialized stores
All types of activities
47.75	Additional activity	Retailing of cosmetics and personal hygiene products in specialized stores

Registration information

Registration date	03.02.2014

Description

APTEKA+, OOO (Moscow Oblast; INN 5050108802) was registered on 3 Feb 2014. The company's authorized capital as of July 1, 2012 was 10000 rub.

Principal activities of APTEKA+, OOO: retailing drugs in specialized stores (pharmacies) (47.73), wholesale of pharmaceutical goods (46.46), retailing products used for medical purposes, orthopedic goods in specialized stores (47.74).

Industry

Economic indicators

2023

Net profit (RAS) of APTEKA+, OOO dropped in 2023 by 27.74% to 8.67 million RUB from 12.00 million RUB over the same period in 2022, the company informed.

Revenue increased in the accounting period by 3.34% to 114.32 million RUB from 110.63 million RUB over 2022.

2022

Net profit (RAS) of APTEKA+, OOO grew over 2022 1.95 times to 12.00 million RUB from 6.16 million RUB over 2021, the company informed.

Revenue increased in the accounting period by 17.39% to 110.63 million RUB from 94.24 million RUB over 2021.

2021

Net profit (RAS) of APTEKA+, OOO dropped in 2021 by 7.47% to 6.16 million RUB from 6.65 million RUB over the same period in 2020, the company informed.

Revenue increased in the accounting period by 2.51% to 94.24 million RUB from 91.93 million RUB over 2020.

2020

Net profit (RAS) of APTEKA+, OOO grew over 2020 3.45 times to 6.65 million RUB from 1.93 million RUB over 2019, the company informed.

Revenue increased in the accounting period by 45.11% to 91.93 million RUB from 63.35 million RUB over 2019.

2019

Net profit (RAS) of APTEKA+, OOO grew over 2019 3.61 times to 1.93 million RUB from 534.00 thousand RUB over 2018, the company informed.

Revenue increased in the accounting period by 15.10% to 63.35 million RUB from 55.04 million RUB over 2018.

2017

Net profit (RAS) of APTEKA+, OOO dropped in 2017 4.11 times to 331.00 thousand RUB from 1.36 million RUB over the same period in 2016, the company informed.

Revenue increased in the accounting period by 10.11% to 43.01 million RUB from 39.06 million RUB over 2016; cost of goods sold grew by 13.46% to 42.44 million RUB from 37.41 million RUB; sales profit fell 2.90 times to 570.00 thousand RUB from 1.66 million RUB.

2016

Net profit (RAS) of APTEKA+, OOO dropped in 2016 by 30.06% to 1.36 million RUB from 1.95 million RUB over the same period in 2015, the company informed.

Revenue increased in the accounting period by 42.61% to 39.06 million RUB from 27.39 million RUB over 2015; cost of goods sold grew by 48.12% to 37.41 million RUB from 25.26 million RUB; sales profit fell by 22.55% to 1.66 million RUB from 2.14 million RUB.

2014

Financial Highlights

Revenue and earnings data

Daily subscription $39 (€32)

unlimited access to database "Kontragent"

download any information within 24 hours

Pay online

Companies in the region

Guarantees

We guarantee

provision of
relevant
information

Payment methods

Statistics

Companies

12 337 637

Reports

17 430 596

Rrocessed requests

Extract from EGRUL:

Today, 1:07 PM

Accounting reports: